At least one Woodward pharmacist is celebrating an action by Oklahoma Attorney General Gentner Drummond that could turn the ...

As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the ...

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...